SavedAdd your journal

Journals / European Journal of Breast Health / 2020 / Cilt: 16 - Sayı: 3

Loco-Regional Treatment for Intact Primary Tumor in Patient with De Novo Metastatic Breast Cancer; Comments and Concerns of ECOG-ACRIN 2108 Trial

Lütfi DOĞAN
Efe SEZGİN
Vahit ÖZMEN
Atilla SORAN
Serdar ÖZBAŞ
Sushil BERIWAL
Adam BRUFSKY
Pages
158–159
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

DOĞAN, L., SEZGİN, E., ÖZMEN, V., SORAN, A., ÖZBAŞ, S., BERIWAL, S., BRUFSKY, A. (2022). Loco-Regional Treatment for Intact Primary Tumor in Patient with De Novo Metastatic Breast Cancer; Comments and Concerns of ECOG-ACRIN 2108 Trial. European Journal of Breast Health, Cilt: 16 - Sayı: 3, 158–159. https://ajindex.com/articles/510740

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Khan SA, Zhao F, Solin LJ, Goldstein LJ, Cella D, Basik M, Golshan M, Julian TB, Pockaj BA, Lee CA, Razaq W, Sparano JA, Babiera GV, Dy IA, Jain S, Silverman P, Fisher C, Tevaarwerk AJ, Wagner LI, Sledge GW. A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: A trial of the ECOG-ACRIN Research Group (E2108). J Clin Oncol 2020; 38(Suppl): pp.LBA2. [Crossref]